Cytosorbents Corporation (CTSO)
NASDAQ: CTSO
· Real-Time Price · USD
1.15
0.01 (0.88%)
At close: Aug 15, 2025, 3:59 PM
1.14
-0.36%
After-hours: Aug 15, 2025, 04:48 PM EDT
Cytosorbents Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 10.2M | 11.59M | 3.28M | 5.69M | 8.46M | 8.61M | 14.13M | 8.36M | 13.15M | 19.05M | 22.14M | 22.55M | 30.16M | 43.02M | 52.14M | 61.04M | 65.61M | 68.47M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 1.52M | 1.52M | 1.48M | 6.48M | 6.48M | 1.48M | 1.48M | 1.69M | 1.69M | n/a | 1.73M | 1.69M | 1.69M | 1.69M | 1.94M | n/a | n/a | n/a |
Other Long-Term Assets | 53K | 50.32K | 22.64K | 3.8M | 3.77M | 3.92M | -3.65M | 4.15M | 4.28M | 6.13M | 1.73M | 4.7M | 4.67M | 4.68M | 1.94M | 4.87M | 4.79M | 4.52M |
Receivables | 7.74M | 7.67M | 7.32M | 6.63M | 7.82M | 6.77M | 6.06M | 6.18M | 7.02M | 5.53M | 5.66M | 4.96M | 5.17M | 4.58M | 4.52M | 5.24M | 5.75M | 5.02M |
Inventory | 3.71M | 3.02M | 2.73M | 3.25M | 4.32M | 3.74M | 3.68M | 2.98M | 2.05M | 1.73M | 3.46M | 3.54M | 4.98M | 5.45M | 4.77M | 4.53M | 3.69M | 3.11M |
Other Current Assets | 1.33M | 3.14M | 8.27M | 1.03M | 1.36M | 880.36K | 1.83M | 1.75M | 1.42M | 1.86M | 2.49M | n/a | 1.33M | 2.81M | n/a | 1.94M | 2.03M | 3.04M |
Total Current Assets | 22.99M | 25.41M | 21.6M | 16.6M | 21.96M | 19.99M | 25.7M | 19.26M | 23.64M | 28.16M | 33.76M | 32.38M | 41.65M | 55.85M | 64.3M | 72.75M | 77.08M | 79.63M |
Property-Plant & Equipment | 19.69M | 20.09M | 20.51M | 20.92M | 21.21M | 21.67M | 22.12M | 22.48M | 22.84M | 23.16M | 23.35M | 23.51M | 23.2M | 21.05M | 18.57M | 17.45M | 16.32M | 3.33M |
Goodwill & Intangibles | 3.74M | 3.7M | 3.75M | n/a | n/a | n/a | 3.91M | n/a | n/a | n/a | 4.39M | n/a | n/a | n/a | 4.7M | n/a | n/a | n/a |
Total Long-Term Assets | 25M | 25.37M | 25.77M | 31.21M | 31.47M | 27.08M | 27.56M | 28.31M | 28.8M | 29.3M | 29.47M | 29.89M | 29.56M | 27.42M | 25.22M | 22.32M | 21.11M | 7.84M |
Total Assets | 47.99M | 50.78M | 47.37M | 47.8M | 53.43M | 47.07M | 53.26M | 47.58M | 52.44M | 57.46M | 63.23M | 62.27M | 71.21M | 83.27M | 89.52M | 95.07M | 98.19M | 87.48M |
Account Payables | 3.39M | 3.33M | 3.34M | 2.34M | 3.05M | 2.4M | 3.8M | 3.44M | 2.84M | 2.99M | 1.66M | 2.35M | 2.13M | 4.83M | 2.81M | 3.36M | 2.17M | 1.68M |
Deferred Revenue | 561K | 546.03K | 419.33K | n/a | 1.3M | 1.6M | 1.38M | -287 | 1.58M | n/a | 1.68M | 1.72M | -416.86K | 2.44M | 2.16M | 2.06M | 1.68M | 1.31M |
Short-Term Debt | 495K | n/a | n/a | n/a | n/a | 2.5M | 2.5M | 833.33K | 114.38K | n/a | n/a | 376.53K | 416.86K | 486.96K | n/a | 265.68K | 251.52K | 462.9K |
Other Current Liabilities | 2M | 796.92K | 865.51K | 837.59K | n/a | n/a | 3.15M | 1.63M | 1.75M | n/a | 5.09M | 1.35M | 1.69M | 1.95M | 7.04M | 1.8M | 1.43M | 850.34K |
Total Current Liabilities | 9.84M | 9.74M | 9.82M | 8.43M | 10.34M | 13.42M | 14.55M | 11.97M | 10.35M | 10.44M | 9.71M | 10.12M | 10.55M | 14.67M | 13.69M | 11.07M | 10.8M | 9.76M |
Long-Term Debt | 26.56M | 14.19M | 14M | 13.81M | 13.67M | 1.93M | 2.54M | 4.2M | 5.02M | 5.01M | 5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 26.56M | 26.5M | 26.44M | 26.37M | 26.35M | 14.72M | 15.44M | 17.09M | 18M | 18.07M | 18.14M | 13.01M | 13.09M | 13.17M | 13.25M | 13.39M | 13.01M | 461.06K |
Total Liabilities | 36.4M | 36.24M | 36.26M | 34.8M | 36.69M | 28.14M | 29.99M | 29.06M | 28.35M | 28.51M | 27.86M | 23.13M | 23.65M | 27.84M | 26.94M | 24.46M | 23.81M | 10.22M |
Total Debt | 27.06M | 26.98M | 26.89M | 26.81M | 26.77M | 17.61M | 18.31M | 18.04M | 18.11M | 18.18M | 18.25M | 13.39M | 13.51M | 13.66M | 13.82M | 13.65M | 13.26M | 923.96K |
Common Stock | 63K | 62.53K | 54.83K | 54.5M | 54.31K | 54.29K | 54.24K | 44.44K | 44.19K | 43.85K | 43.63K | 43.63K | 43.58K | 43.51K | 43.48K | 43.48K | 43.34K | 43.27K |
Retained Earnings | -303.54M | -305.49M | -304.01M | -295.34M | -293.01M | -288.86M | -282.51M | -276.67M | -267.48M | -261.32M | -254M | -253.23M | -241.03M | -230.15M | -221.19M | -211.88M | -205.47M | -200.79M |
Comprehensive Income | -3.96M | 1.52M | 4.25M | -156.93K | 2.17M | 1.75M | 529.32K | 2.98M | 1.33M | 1.72M | 2.33M | 6.2M | 3.54M | 1.49M | 525.59K | -32.88K | -840.84K | -576.34K |
Shareholders Equity | 11.59M | 14.54M | 11.11M | 13M | 16.74M | 18.93M | 23.28M | 18.51M | 24.09M | 28.96M | 35.37M | 39.14M | 47.56M | 55.43M | 62.58M | 70.61M | 74.38M | 77.26M |
Total Investments | 1.52M | 1.52M | 1.48M | 6.48M | 6.48M | 1.48M | 1.48M | 1.69M | 1.69M | n/a | 1.73M | 1.69M | 1.69M | 1.69M | 1.94M | n/a | n/a | n/a |